ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0433

Clustering of Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis – Using a Pre-processed Harmonised Dataset

Karl Gisslander1, Arthur White2, Mårten Segelmark3, Mark Little2 and Aladdin Mohammad4, 1Lund University, Lund, Sweden, 2Trinity College, Dublin, Ireland, 3Nephrology, Department of Clinical Sciences, Lund University, Lund, Sweden, 4Rheumatology, Department of Clinical Sciences, Lund University, Lund, Sweden

Meeting: ACR Convergence 2022

Keywords: ANCA associated vasculitis, classification criteria, registry, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Vasculitis – ANCA-Associated Poster I: Epidemiology, Outcomes, and Classification

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: The sub-classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) has been a long-standing debate. Unsupervised learning has previously been used for partitioning of phenotypic groups, but as AAV is a rare disease, small sample sizes have been a limiting factor. Here we attempt clustering of a small dataset harmonised to the FAIRVASC ontology, allowing potential future inclusion of an additional 5000 AAV patients from the FAIRVASC collaboration registries to the cluster model. FAIRVASC is a research project seeking to federate AAV registries across Europe using semantic web technologies (https://fairvasc.eu).

Methods: This study used a dataset of 292 patients from southern Sweden, classified as granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA), according to the European Medicines Agency algorithm. The dataset was pre-processed from a relational database format to a resource descriptive framework (RDF) graph-based data model, harmonising the dataset to a FAIRVASC standard. Factor analysis of mixed data (FAMD) and agglomerative hierarchical cluster analysis on principal components (HCPC) was used to develop a cluster model, including organ pattern, ANCA status, serum creatinine, C-reactive protein, gender, and age at diagnosis. The generated clusters were evaluated by baseline characteristics, mortality, and renal outcome.

Results: The analyses involved data for 163 subjects with GPA and 129 with MPA. The clustering model resulted in two larger clusters and three smaller ones. The larger clusters were a predominantly anti-PR3 positive cluster of young (mean 57.5 years at diagnosis) patients with ear-nose-throat involvement and a favourable outcome (Cluster 1), and a predominantly anti-MPO positive cluster with severe kidney involvement and high rates of mortality and end-stage kidney disease (Cluster 5). The three smaller clusters differed in terms of organ involvement and ANCA status at diagnosis, one with severe lung and renal involvement and a poor outcome (Cluster 3) and two with similar outcome, one ANCA negative (Cluster 4), and one with peripheral nerve involvement (Cluster 2). The descriptive characteristics of the clusters are presented in table 1.

Conclusion: Our analysis suggests five clusters of AAV patients based on baseline features, associated with different mortality and renal outcome. The investigation acts as a proof of concept of the FAIRVASC ontology and infrastructure for the harmonisation of heterogeneous AAV datasets. The cluster model may in the future readily include an unprecedented number of European AAV patients.

Supporting image 1

Table 1. Baseline characteristics and outcome of 292 patients with AAV by diagnosis and cluster affiliation


Disclosures: K. Gisslander, None; A. White, None; M. Segelmark, None; M. Little, None; A. Mohammad, None.

To cite this abstract in AMA style:

Gisslander K, White A, Segelmark M, Little M, Mohammad A. Clustering of Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis – Using a Pre-processed Harmonised Dataset [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/clustering-of-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-using-a-pre-processed-harmonised-dataset/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clustering-of-anti-neutrophil-cytoplasmic-antibody-associated-vasculitis-using-a-pre-processed-harmonised-dataset/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology